BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 27439892)

  • 1. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.
    Ding Y; Zhang M; Zhang W; Lu Q; Cai Z; Song P; Okon IS; Xiao L; Zou MH
    Circ Res; 2016 Sep; 119(6):718-30. PubMed ID: 27439892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein deglycase DJ-1 deficiency induces phenotypic switching in vascular smooth muscle cells and exacerbates atherosclerotic plaque instability.
    Wang ZY; Cheng J; Liu B; Xie F; Li CL; Qiao W; Lu QH; Wang Y; Zhang MX
    J Cell Mol Med; 2021 Mar; 25(6):2816-2827. PubMed ID: 33501750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In Vivo.
    Cai Z; Ding Y; Zhang M; Lu Q; Wu S; Zhu H; Song P; Zou MH
    Circ Res; 2016 Jul; 119(3):422-33. PubMed ID: 27256105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired autophagy mediates hyperhomocysteinemia-induced HA-VSMC phenotypic switching.
    Ni T; Gao F; Zhang J; Lin H; Luo H; Chi J; Guo H
    J Mol Histol; 2019 Aug; 50(4):305-314. PubMed ID: 31028566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
    Shi X; Zhang Y; Han J; Peng W; Fang Z; Qin Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
    J Cardiovasc Pharmacol; 2021 May; 77(5):642-649. PubMed ID: 33951699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation.
    Song P; Zhou Y; Coughlan KA; Dai X; Xu H; Viollet B; Zou MH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2800-9. PubMed ID: 24115035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability.
    Chen MY; Ke JF; Zhang ZH; Li MF; Wang JW; Lu JX; Xu PP; Xia XT; Guo MG; Li LX
    Atherosclerosis; 2021 Sep; 333():39-47. PubMed ID: 34425526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
    Zhu H; Wang Z; Dong Z; Wang C; Cao Q; Fan F; Zhao J; Liu X; Yuan M; Sun X; Peng X; Zou Y; Zhou J; Ge J; Zhou X; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1782-1792. PubMed ID: 30315930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis.
    Vendrov AE; Sumida A; Canugovi C; Lozhkin A; Hayami T; Madamanchi NR; Runge MS
    Redox Biol; 2019 Feb; 21():101063. PubMed ID: 30576919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development
    Hu DJ; Li ZY; Zhu YT; Li CC
    Aging (Albany NY); 2020 Dec; 13(3):4299-4316. PubMed ID: 33411680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.
    Song P; Wang S; He C; Wang S; Liang B; Viollet B; Zou MH
    Circ Res; 2011 Nov; 109(11):1230-9. PubMed ID: 21980125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling.
    Sunaga H; Matsui H; Anjo S; Syamsunarno MR; Koitabashi N; Iso T; Matsuzaka T; Shimano H; Yokoyama T; Kurabayashi M
    J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27881420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tribulus terrestris L. extract ameliorates atherosclerosis by inhibition of vascular smooth muscle cell proliferation in ApoE
    Zhang J; Zhao WR; Shi WT; Tan JJ; Zhang KY; Tang JY; Chen XL; Zhou ZY
    J Ethnopharmacol; 2022 Oct; 297():115547. PubMed ID: 35870688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.
    Shai SY; Sukhanov S; Higashi Y; Vaughn C; Kelly J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1916-24. PubMed ID: 20671230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice.
    Murugesan V; Degerman E; Holmen-Pålbrink AK; Duner P; Knutsson A; Hultgårdh-Nilsson A; Rauch U
    J Vasc Res; 2017; 54(4):235-245. PubMed ID: 28768281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-145 targeted therapy reduces atherosclerosis.
    Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
    Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-Specific Deletion of the AMPKα2 Subunit Alters Monocyte Protein Expression and Atherogenesis.
    Fisslthaler B; Zippel N; Abdel Malik R; Delgado Lagos F; Zukunft S; Thoele J; Siuda D; Soehnlein O; Wittig I; Heidler J; Weigert A; Fleming I
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.